abbvie
Pharma

AbbVie scores FDA green light for another ImmunoGen asset

AbbVie's ImmunoGen buyout continues to pay off, thanks to a new FDA nod for an antibody-drug conjugate for a rare form of blood cancer.
Fraiser Kansteiner May 28, 2026 7:27am
Getty Image picture of peanut butter and nuts to show allergy

Kaléo speaks up on allergy awareness to amplify patient stories

May 28, 2026 3:57am
Eliminating KRAS Why targeted protein degraders could redefinewhatspossible in cancer

Eliminating KRAS: How degraders could redefine cancer care

Brought to you by ASTELLAS
Graphic of two hands shaking under a red and purple light

Viridian, awaiting FDA decision, taps WuXi Bio in supply deal

May 27, 2026 3:32pm
Real-World Evidence in the AI Era What You Can Unlock Depends on What You Build On

RWE in the AI Era: What You Unlock Depends on What You Build On

Brought to you by Flatiron Health
mountain climb steep cliff climber struggle

Previewing Akeso's high-stakes ASCO plenary for PD-1/VEGF

May 27, 2026 11:25am
More News

J&J dismisses 56 from HQ as part of orthopedics separation

May 27, 2026 11:14am

CordenPharma to snap up peptide API maker with US, China sites

May 27, 2026 10:39am

Outlook wins FDA appeal after formal dispute proceedings

May 27, 2026 8:26am

US healthcare, life sci could benefit from disruption: poll

May 27, 2026 8:00am